Solésence Reports Record $62.1M Revenue for 2025, Full-Year Net Income Halves
summarizeSummary
Solésence reported mixed financial results for the fourth quarter and full-year 2025. The company achieved record full-year revenue of $62.1 million, a 19% increase year-over-year, driven by growth in consumer products. However, full-year net income significantly declined to $1.8 million from $4.2 million in 2024, and gross margin compressed from 31% to 26%. For the fourth quarter, revenue was flat at $12.5 million, but the company swung to a net income of $0.2 million from a $0.6 million loss in the prior year period, with gross margin improving to 27%. Management highlighted a new strategic initiative, "Transform & Transcend," aimed at driving sustainable, profitable growth. Traders will be watching if the Q4 profitability improvements can be sustained and if the strategic initiatives can reverse the full-year margin and net income declines.
في وقت هذا الإعلان، كان SLSN يتداول عند ٠٫٩٠ US$ في NASDAQ ضمن قطاع Life Sciences، مع قيمة سوقية تقارب ٦٣٫٥ مليون US$. تراوح نطاق التداول خلال 52 أسبوعًا بين ٠٫٧٨ US$ و١٦٫٥٦ US$. تم تقييم هذا الخبر على أنه ذو معنويات سوقية محايدة وبدرجة أهمية ٨ من 10. المصدر: GlobeNewswire.